During the quarter, Starpharma received its initial orders to supply Viraleze™ to Saudi Arabia through our distribution partner, Etqan & Nazahah LLC (E&N). E&N is a privately owned agent and distributor of medical and pharmaceutical products, representing international healthcare companies in the Gulf Cooperation Council (GCC) region and other neighbouring countries. Since announcing our sales and distribution agreement in February 20221 , Starpharma has worked closely with E&N to reach this milestone
ITROM Pharmaceutical Group, our VivaGel® BV distribution partner for the Middle East and North Africa, launched the product in Saudi Arabia and the United Arab Emirates (UAE) in April. Regulatory activities continue to progress for other countries under the agreement.
SPL Price at posting:
9.2¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)